Your Community

Fast-Tracking Innovation: The FDA’s Process for Approving New Cancer Therapies

2024-05-08T14:38:23-05:00May 2nd, 2024|Hot Topics, Newsletter Articles, Science and Research, Your Community|

Author: Matthew Reiss, MSE, PhD, Manager, Precision Medicine & Navigation, GO2 for Lung Cancer  The first anti-cancer therapy, mechlorethamine, was approved in 1949. Since then, the U.S. Food and Drug Administration (FDA) has worked to ensure that new lifesaving [...]

2024 Lung Cancer Support Group Facilitator Awardee, Christine Conti

2024-03-25T10:19:57-05:00March 25th, 2024|Hot Topics, News, Newsletter Articles, Your Community|

Congratulations to our 2024 Lung Cancer Support Group Facilitator award recipient, Christine Conti, from Huntington Health in Pasadena, California. This award, given annually since 2009, recognizes the uncommon dedication of support group facilitators. Christine Conti, RN, ONN-CG, is a thoracic [...]

Go to Top